Cite
MLA Citation
Stephen D. Silberstein et al.. “Safety and Tolerability of Fremanezumab for the Prevention of Migraine: A Pooled Analysis of Phases 2b and 3 Clinical Trials.” Headache, vol. 59, no. 6, 2019, pp. 880–890. http://access.bl.uk/ark:/81055/vdc_100085406904.0x000047